Gerjan Navis - Concepedia

Author

Gerjan Navis

Also Known As

Alan B. Weder, Andrew D. Johnson, Boer, Rudolf A De, G. J. Navis, G. Navis, GERJAN J. NAVIS, Gerard Waeber, Gerjan J Navis, Gerjan J. Navis, Gerjan Navis

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Isala TiFN Wageningen University & Research

About

Gerjan Navis is an author at University Medical Center Groningen specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.3K
2	Health Sciences	6	6	950
3	Public Health	2	2	186
4	Biochemistry	2	2	182
5	Social Sciences	1	1	17

Gerjan Navis

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis Patients Robbert Meerwaldt, Jasper W.L. Hartog, Reindert Graaff, Journal of the American Society of Nephrology AgingSkin AutofluorescenceDialysis TherapyDermatologyHemodialysis Patients	2005	410
A central body fat distribution is related to renal function impairment, even in lean subjects Sara‐Joan Pinto‐Sietsma, Gerjan Navis, Wilbert M.T. Janssen, American Journal of Kidney Diseases ObesityMetabolic SyndromeNutritionRenal FunctionBody Composition	2003	359
Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study Ali Abbasi, Linda M. Peelen, Eva Corpeleijn, BMJ	2012	309
Implementation of proteomic biomarkers: making it work Harald Mischak, John P. A. Ioannidis, Àngel Argilés, European Journal of Clinical Investigation Valid BiomarkersProteomic TechnologyBiomarker (Medicine)BiostatisticsBiomarker Discovery	2012	168
Congestion in Chronic Systolic Heart Failure is Related to Renal Dysfunction and Increased Mortality Kevin Damman, Adriaan A. Voors, Hans L. Hillege, European Journal of Heart Failure	2010	159
Bilirubin as a Potential Causal Factor in Type 2 Diabetes Risk: A Mendelian Randomization Study Ali Abbasi, Petronella E. Deetman, Eva Corpeleijn, Diabetes	2014	119
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy Alaa Alkhalaf, Astrid Klooster, Willem van Oeveren, Diabetes Care	2010	106
Dietary Acid Load and Metabolic Acidosis in Renal Transplant Recipients Else van den Berg, Mariëlle F. Engberink, Elizabeth J. Brink, Clinical Journal of the American Society of Nephrology	2012	105
Urinary and plasma magnesium and risk of ischemic heart disease Michel M. Joosten, Ron T. Gansevoort, Kenneth J. Mukamal, American Journal of Clinical Nutrition Electrolyte DisorderUrologyPlasma MagnesiumCardiovascular DiseaseMedicine	2013	103
Urinary Creatinine Excretion Reflecting Muscle Mass is a Predictor of Mortality and Graft Loss in Renal Transplant Recipients Leendert H. Oterdoom, Rutger M. van Ree, Aiko P. J. de Vries, Transplantation	2008	99

Page 1